Reply to letter to editor by Duo Yun, MD regarding our article, "A striking elevation of CA19-9 after preoperative therapy negates prognostic benefit from radical surgery in resectable or borderline resectable pancreatic cancer"

Surgery. 2024 Dec 20:108952. doi: 10.1016/j.surg.2024.11.003. Online ahead of print.

¹ Department of Surgery, Osaka International Cancer Institute, Osaka, Japan. Electronic address: [email protected].
² Department of Surgery, Osaka International Cancer Institute, Osaka, Japan.

No abstract available

Publication types